Scott A. Brown

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir”.

NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir

Nature Communications(2021)10.1038/s41467-021-24509-7

N/A

0DataRank · unranked

24 citations

Takanori Mizuno, Daniel Rehling, Colton Smith, Brandi L. Clark, Xujie Zhao +14 more

AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.10.007

N/A

0DataRank · unranked

23 citations

Rosario Mosca, Elida Gomero, Diantha van de Vlekkert, Yvan Campos, Leigh E. Fremuth +5 more

Low NUDT15 expression levels due to biallelic NUDT15 variants and 6‐mercaptopurine intolerance

British Journal of Haematology(2022)10.1111/bjh.18375

N/A

0DataRank · unranked

5 citations

Scott A. Brown, Takaya Moriyama, Rina Nishii, Shin‐ichi Tsujimoto, Yuji Yamada +19 more

AAV-mediated gene therapy for Sialidosis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.10.566667

N/A

0DataRank · unranked

1 citations

Huimin Hu, Leigh E. Fremuth, Scott A. Brown, Jason A. Weesner, Elida Gomero +3 more

AAV-mediated gene therapy for sialidosis

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.029

N/A

0DataRank · unranked

9 citations

Huimin Hu, Jason A. Weesner, Leigh E. Fremuth, Scott A. Brown, Meifen Lu +5 more